These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2872630)

  • 1. Striatal neuropeptide Y neurones are under the influence of the nigrostriatal dopaminergic pathway: immunohistochemical evidence.
    Kerkerian L; Bosler O; Pelletier G; Nieoullon A
    Neurosci Lett; 1986 May; 66(1):106-12. PubMed ID: 2872630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrastriatal transplants of embryonic dopaminergic neurons counteract the increase of striatal enkephalin immunostaining but not serotoninergic sprouting elicited by a neonatal lesion of the nigrostriatal dopaminergic pathway.
    Abrous DN; Manier M; Mennicken F; Feuerstein C; Le Moal M; Herman JP
    Eur J Neurosci; 1993 Feb; 5(2):128-36. PubMed ID: 7903185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of dopaminergic influence on expression of neuropeptide Y immunoreactivity by rat striatal neurons.
    Kerkerian L; Salin P; Nieoullon A
    Neuroscience; 1988 Sep; 26(3):809-17. PubMed ID: 3143926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efferent synaptic connections of grafted dopaminergic neurons reinnervating the host neostriatum: a tyrosine hydroxylase immunocytochemical study.
    Freund TF; Bolam JP; Björklund A; Stenevi U; Dunnett SB; Powell JF; Smith AD
    J Neurosci; 1985 Mar; 5(3):603-16. PubMed ID: 2857778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin-immunoreactive neurons in the rat striatum: effects of corticostriatal and nigrostriatal dopaminergic lesions.
    Salin P; Kerkerian-Le Goff L; Heidet V; Epelbaum J; Nieoullon A
    Brain Res; 1990 Jun; 521(1-2):23-32. PubMed ID: 1976412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of the adaptive response of neuropeptide Y neurons in the rat striatum to nigrostriatal dopamine deafferentation by the N-methyl-D-aspartate antagonist dizocilpine maleate.
    Salin P; Nieoullon A; Kerkerian-Le Goff L
    Neuroscience; 1994 Jul; 61(1):93-105. PubMed ID: 7969899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase of striatal methionin enkephalin content following lesion of the nigrostriatal dopaminergic pathway in adult rats and reversal following the implantation of embryonic dopaminergic neurons: a quantitative immunohistochemical analysis.
    Manier M; Abrous DN; Feuerstein C; Le Moal M; Herman JP
    Neuroscience; 1991; 42(2):427-39. PubMed ID: 1896133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological analysis of the functional ontogeny of the nigrostriatal dopaminergic neurons.
    Cheronis JC; Erinoff L; Heller A; Hoffmann PC
    Brain Res; 1979 Jun; 169(3):545-60. PubMed ID: 36209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y-immunoreactive neurons receive synaptic inputs from dopaminergic axon terminals in the rat neostriatum.
    Kubota Y; Inagaki S; Kito S; Shimada S; Okayama T; Hatanaka H; Pelletier G; Takagi H; Tohyama M
    Brain Res; 1988 Aug; 458(2):389-93. PubMed ID: 2905200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lesions of the dopaminergic nigrostriatal pathway alter preprosomatostatin messenger RNA levels in the striatum, the entopeduncular nucleus and the lateral hypothalamus of the rat.
    Soghomonian JJ; Chesselet MF
    Neuroscience; 1991; 42(1):49-59. PubMed ID: 1677745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine administration increases striatal dopamine release in rats with partial nigrostriatal lesions.
    Melamed E; Hefti F; Wurtman RJ
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4305-9. PubMed ID: 6254020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of neuropeptide Y immunoreactivity in the rat nucleus accumbens is under the influence of the dopaminergic mesencephalic pathway.
    Salin P; Kerkerian L; Nieoullon A
    Exp Brain Res; 1990; 81(2):363-71. PubMed ID: 1975787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrastructural correlates of functional relationships between nigral dopaminergic or cortical afferent fibers and neuropeptide Y-containing neurons in the rat striatum.
    Vuillet J; Kerkerian L; Kachidian P; Bosler O; Nieoullon A
    Neurosci Lett; 1989 May; 100(1-3):99-104. PubMed ID: 2761790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single dopaminergic nigrostriatal neurons form two chemically distinct synaptic types: possible transmitter segregation within neurons.
    Hattori T; Takada M; Moriizumi T; Van der Kooy D
    J Comp Neurol; 1991 Jul; 309(3):391-401. PubMed ID: 1717519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. gamma-Aminobutyric acid function in the rat striatum is under the double influence of nigrostriatal dopaminergic and thalamostriatal inputs: two modes of regulation?
    Samuel D; Kumar U; Nieoullon A
    J Neurochem; 1988 Dec; 51(6):1704-10. PubMed ID: 3141584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are bilateral nigrostriatal dopaminergic pathways functionally linked in the rat brain? A microdialysis study in conscious rats.
    Santiago M; Cano J; Westerink BH
    Brain Res; 1993 Nov; 628(1-2):187-92. PubMed ID: 8313146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous regeneration of nigrostriatal dopaminergic neurons in MPTP-treated C57BL/6 mice.
    Mitsumoto Y; Watanabe A; Mori A; Koga N
    Biochem Biophys Res Commun; 1998 Jul; 248(3):660-3. PubMed ID: 9703982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal cord dopaminergic neurons: evidence for an uncrossed nigrospinal pathway.
    Commissiong JW; Gentleman S; Neff NH
    Neuropharmacology; 1979 Jun; 18(6):565-8. PubMed ID: 481709
    [No Abstract]   [Full Text] [Related]  

  • 19. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density.
    Masuo Y; Pélaprat D; Montagne MN; Scherman D; Rostène W
    Brain Res; 1990 Mar; 510(2):203-10. PubMed ID: 1970504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lesions of nigrostriatal pathway reduce expression of tyrosine hydroxylase gene in residual dopaminergic neurons of substantia nigra.
    Shirao T; Evinger MJ; Iacovitti L; Reis DJ
    Neurosci Lett; 1992 Jul; 141(2):208-12. PubMed ID: 1359468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.